PROPOVEN

This brand name is authorized in Estonia, Ireland, Lithuania, United Kingdom

Active ingredients

The drug PROPOVEN contains one active pharmaceutical ingredient (API):

1 Propofol UNII YI7VU623SF - PROPOFOL

Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds. Read about Propofol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROPOVEN Emulsion for injection/infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N01AX10	Propofol	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1160851, 1160862, 1160873, 1160884, 1160895, 1160907, 1160918, 1160929, 1160930, 1160941, 1160974, 1160985, 1160996, 1538513, 1538524, 1666223, 1666234, 1666302, 1708387, 1736007, 1830686, 1830697
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 365334, 365336, 365338, 366128
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1017504, 1017505, 1017506, 1017508, 1017509, 1017510, 1017511, 1017512, 1017513, 1017514, 1017515, 1017516, 1017517, 1062020, 1062021, 1071838, 1071839, 1077827, 1079494, 1081699, 1090986, 1090987